CD274 and neoplasm: The present model integrates the processes involved in the patient, including APC maturation, T-cell activation, T-cell trafficking and tumour rejection, which allows us to investigate the effects of several factors such as pretreatment tumour size, tumour growth rate, PD-L1 expression and antigen intensity on a more comprehensive scale.